229 results on '"A. Thalmann"'
Search Results
2. Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial
3. Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries
4. Effect of Simulation-based Training on Surgical Proficiency and Patient Outcomes: A Randomised Controlled Clinical and Educational Trial
5. The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma
6. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
7. Corrigendum to “European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines” [Eur. Urol. 85 (2024) 17–31]
8. Consistencies in follow-up after radical cystectomy for bladder cancer: A practice-based framework by collaborative EAU bladder cancer guideline panels
9. Characterization of the tumor microenvironment in prostate cancer progression
10. Individual patient data validation of the definitions of BCG failure in patients with non-muscle invasive urothelial carcinoma of the bladder: An international multi-centre retrospective study
11. EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees
12. In memoriam Urs Studer (1944–2023)
13. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
14. Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
15. An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer
16. Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy
17. Do current definitions of BCG failure/ BCG unresponsive NMIBCs correlate with disease progression? Results of an individual patient data validation international multi-center retrospective study
18. Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries
19. Patient-derived organoids as a promising preclinical model for assessing therapy response in bladder cancer
20. Erratum to “Effect of Simulation-based Training on Surgical Proficiency and Patient Outcomes: A Randomised Controlled Clinical and Educational Trial” [Eur Urol 2022;81:385–393]
21. Patient-derived organoids as a promising preclinical model for assessing therapy response in bladder cancer
22. Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial
23. A Prospective Randomised Trial Comparing the Modified HM3 with the MODULITH® SLX-F2 Lithotripter
24. Irrigation of Continent Catheterizable Ileal Pouches: Tap Water Can Replace Sterile Solutions Because It Is Safe, Easy, and Economical
25. Readaptation of the Peritoneum Following Extended Pelvic Lymphadenectomy and Cystectomy Has a Significant Beneficial Impact on Early Postoperative Recovery and Complications: Results of a Prospective Randomized Trial
26. The Role of Choline Positron Emission Tomography/Computed Tomography in the Management of Patients with Prostate-Specific Antigen Progression After Radical Treatment of Prostate Cancer
27. Effect of Simulation-based Training on Surgical Proficiency and Patient Outcomes: A Randomised Controlled Clinical and Educational Trial
28. Identification of tumor heterogeneity and drug sensitivity in primary prostate cancer
29. Bladder cancer master regulators; a multi-modal precision oncology framework
30. Erratum to 'Effect of Simulation-based Training on Surgical Proficiency and Patient Outcomes: A Randomised Controlled Clinical and Educational Trial' [Eur Urol 2022;81:385–393]
31. A0854 - Consistencies in follow-up after radical cystectomy for bladder cancer: A practice-based framework by collaborative EAU bladder cancer guideline panels
32. A0845 - Individual patient data validation of the definitions of BCG failure in patients with non-muscle invasive urothelial carcinoma of the bladder: An international multi-centre retrospective study
33. A0544 - Characterization of the tumor microenvironment in prostate cancer progression
34. P160 - Generation of a new transgenic mouse model to explore the role of oncofetal CRIPTO in lethal prostate cancer
35. Human Prostate Fibroblasts Induce Growth and Confer Castration Resistance and Metastatic Potential in LNCaP Cells
36. A New Multimodality Technique Accurately Maps the Primary Lymphatic Landing Sites of the Bladder
37. An Updated Critical Analysis of the Treatment Strategy for Newly Diagnosed High-grade T1 (Previously T1G3) Bladder Cancer
38. A genetically engineered mouse model to study oncofetal CRIPTO in aggressive lethal prostate cancer
39. Application of a new 3D culture system to culture uniformly sized patient-derived bladder cancer (BLCa) organoids
40. Identifying drug sensitivity of multifocal primary prostate cancer
41. Characterization of bladder cancer patient-derived organoids and potential application for personalized medicine
42. Exploring the role of androgen signaling in prostate cancer stroma
43. Re: Impact of the Implementation of the EAU Guidelines Recommendation on Reporting and Grading of Complications in Patients Undergoing Robot-assisted Radical Cystectomy: A Systematic Review
44. Good Outcome for Patients with Few Lymph Node Metastases After Radical Retropubic Prostatectomy
45. Diabetes Mellitus: Does It Impair Urinary Continence after Radical Cystoprostatectomy and Ileal Orthotopic Bladder Substitution?
46. The Template of the Primary Lymphatic Landing Sites of the Prostate Should Be Revisited: Results of a Multimodality Mapping Study
47. Corrigendum to ‘EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees’ [European Urology 77 (2020) 223–250]
48. Bladder cancer: Patient-derived organoids as a tool for precision medicine
49. Synergic AR and dual-mTOR blockade delays advanced prostate cancer growth and alters tumor heterogeneity
50. The role of CRIPTO signaling in lethal prostate cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.